AIM: To evaluate prospectively usefulness of fecal lactoferrin (Lf) and fecal hemoglobin (Hb) in the diagnosis of colorectal diseases. METHODS: Fecal Lf and Hb were measured using ELISA in 872 patients before they underwent colorectal endoscopy. RESULTS: Lf was positive in 18 (50%) of 36 patients with colorectal cancer, 25 (15.9%) of 157 with colorectal polyps, 29 (46.8%) of 62 with ulcerative colitis, and 25 (62.5%) of 40 (62.5%) with Crohn's disease. The Hb-positive rates were 50%, 12.1%, 41.9% and 32.5%, respectively. Of the 318 patients free of abnormalities by colorectal endoscopy, Lf was positive in 29 (9.1%) and Hb was positive in 15 (4.7%). Among patients with Crohn's disease, the Lf-positive rate was significantly higher than the Hb-positive rate. If either high Lf or Hb levels were considered positive, the positive rates rose to 61.1%, 51.6%, and 67.5% in the colorectal cancer group, ulcerative colitis group, and Crohn's disease group, respectively. If both high Lf and Hb levels were rated positive, the positive predictive values (PPV) were 21% for colorectal cancer, 33% for ulcerative colitis, and 17% for Crohn's disease, and PPV of high Hb level alone was 18%, 25% and 13%, respectively. CONCLUSION: Fecal Lf and Hb were found useful in the detection of colorectal diseases, and the combination of the two measurements appears to increase the sensitivity and efficacy of diagnosis.
AIM: To evaluate prospectively usefulness of fecal lactoferrin (Lf) and fecal hemoglobin (Hb) in the diagnosis of colorectal diseases. METHODS: Fecal Lf and Hb were measured using ELISA in 872 patients before they underwent colorectal endoscopy. RESULTS: Lf was positive in 18 (50%) of 36 patients with colorectal cancer, 25 (15.9%) of 157 with colorectal polyps, 29 (46.8%) of 62 with ulcerative colitis, and 25 (62.5%) of 40 (62.5%) with Crohn's disease. The Hb-positive rates were 50%, 12.1%, 41.9% and 32.5%, respectively. Of the 318 patients free of abnormalities by colorectal endoscopy, Lf was positive in 29 (9.1%) and Hb was positive in 15 (4.7%). Among patients with Crohn's disease, the Lf-positive rate was significantly higher than the Hb-positive rate. If either high Lf or Hb levels were considered positive, the positive rates rose to 61.1%, 51.6%, and 67.5% in the colorectal cancer group, ulcerative colitis group, and Crohn's disease group, respectively. If both high Lf and Hb levels were rated positive, the positive predictive values (PPV) were 21% for colorectal cancer, 33% for ulcerative colitis, and 17% for Crohn's disease, and PPV of high Hb level alone was 18%, 25% and 13%, respectively. CONCLUSION: Fecal Lf and Hb were found useful in the detection of colorectal diseases, and the combination of the two measurements appears to increase the sensitivity and efficacy of diagnosis.
Authors: J Kristinsson; K Nygaard; E Aadland; S Barstad; J Sauar; B Hofstad; N Stray; A Stallemo; B Haug; M Ugstad; H Tøn; P Fuglerud Journal: Digestion Date: 2001 Impact factor: 3.216
Authors: D A Ahlquist; J E Skoletsky; K A Boynton; J J Harrington; D W Mahoney; W E Pierceall; S N Thibodeau; A P Shuber Journal: Gastroenterology Date: 2000-11 Impact factor: 22.682
Authors: S M Dong; G Traverso; C Johnson; L Geng; R Favis; K Boynton; K Hibi; S N Goodman; M D'Allessio; P Paty; S R Hamilton; D Sidransky; F Barany; B Levin; A Shuber; K W Kinzler; B Vogelstein; J Jen Journal: J Natl Cancer Inst Date: 2001-06-06 Impact factor: 13.506
Authors: O Saitoh; K Kojima; K Sugi; R Matsuse; K Uchida; K Tabata; K Nakagawa; M Kayazawa; I Hirata; K Katsu Journal: Am J Gastroenterol Date: 1999-12 Impact factor: 10.864
Authors: Sunanda V Kane; William J Sandborn; Paul A Rufo; Anna Zholudev; James Boone; David Lyerly; Michael Camilleri; Stephen B Hanauer Journal: Am J Gastroenterol Date: 2003-06 Impact factor: 10.864
Authors: Vojtech Adam; Ondrej Zitka; Petr Dolezal; Ladislav Zeman; Ales Horna; Jaromir Hubalek; Jan Sileny; Sona Krizkova; Libuse Trnkova; Rene Kizek Journal: Sensors (Basel) Date: 2008-01-24 Impact factor: 3.576
Authors: Sang Soo Lee; Hyun Ju Min; Ja Yun Choi; Hyun Chin Cho; Jin Joo Kim; Jae Min Lee; Hong Jun Kim; Chang Yoon Ha; Hyun Jin Kim; Tae Hyo Kim; Jin Hyun Kim; Ok-Jae Lee Journal: BMC Gastroenterol Date: 2016-10-13 Impact factor: 3.067
Authors: Kristina M Bridges; Francisco J Diaz; Zhiwen Wang; Ishfaq Ahmed; Debra K Sullivan; Shahid Umar; Daniel C Buckles; K Allen Greiner; Christina M Hester Journal: Genes (Basel) Date: 2018-02-26 Impact factor: 4.096